Patents by Inventor Rolf Swoboda

Rolf Swoboda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10968444
    Abstract: The present invention provides a method for preparing a modular scaffold that can bind to a target antigen and a method for engineering a bispecific functional agent consisting of an existing polypeptide binder fused at its C-terminus with said modular scaffold.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: April 6, 2021
    Assignee: Abzyme Therapeutics LLC
    Inventors: Hiep Tran, Xiaole Chen, Christine Mary Prokopowitz, Rolf Swoboda, Ian White
  • Patent number: 10704040
    Abstract: The present invention provides a triple-mode antibody display system that simultaneously matures, displays and secretes an antibody to a target of interest. An antibody in vivo-matured and complexed with membrane anchored bait can be expressed on the surface of the host cell, while complexed with a soluble bait the antibody is secreted from the host cell. Methods of using the system for identifying binders that bind specifically to an antigen of interest are also provided. Polypeptides, polynucleotides and host cells useful for making the protein binder display system are also provided along with methods of use thereof.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: July 7, 2020
    Assignee: Abzyme Therapeutics LLC
    Inventors: Hiep Tran, Xiaole Chen, Hung Pham, Christine Mary Prokopowitz, Rolf Swoboda, Ian White
  • Publication number: 20180334668
    Abstract: The present invention provides a triple-mode antibody display system that simultaneously matures, displays and secretes an antibody to a target of interest. An antibody in vivo-matured and complexed with membrane anchored bait can be expressed on the surface of the host cell, while complexed with a soluble bait the antibody is secreted from the host cell. Methods of using the system for identifying binders that bind specifically to an antigen of interest are also provided.
    Type: Application
    Filed: May 22, 2018
    Publication date: November 22, 2018
    Inventors: Hiep Tran, Xiaole Chen, Hung Pham, Christine Mary Prokopowitz, Rolf Swoboda, Ian White
  • Publication number: 20180334666
    Abstract: The present invention provides a method for preparing a modular scaffold that can bind to a target antigen and a method for engineering a bispecific functional agent consisting of an existing polypeptide binder fused at its C-terminus with said modular scaffold.
    Type: Application
    Filed: July 10, 2018
    Publication date: November 22, 2018
    Inventors: Hiep Tran, Xiaole Chen, Christine Mary Prokopowitz, Rolf Swoboda, Ian White
  • Publication number: 20170183645
    Abstract: Provided, among other things, is a yeast cell comprising: (A) a recombinant DNA that constitutively or inducibly expresses a cytidine deaminase comprising sequence with about 90% sequence identity or more with a cytidine deaminase domain of (i) SEQ ID NO. 2 or SEQ ID NO. 4, or (ii) a chimera between the two starting with SEQ ID NO. 3 or SEQ ID NO. 4 sequence and having one transition to end in SEQ ID NO. 1 or SEQ ID NO. 2 sequence, or (iii) a chimera between the two starting with SEQ ID NO. 1 or SEQ ID NO. 2 sequence and having one transition to end in SEQ ID NO. 3 or SEQ ID NO. 4 sequence; and (B) a second recombinant DNA that constitutively or inducibly expresses a binding scaffold protein for presentation on the outer surface of the yeast, wherein the cytidine deaminase as expressed by the first recombinant DNA is effective to contribute to a mutagenic process for inducing mutations in the binding scaffold protein of the yeast cell.
    Type: Application
    Filed: December 15, 2016
    Publication date: June 29, 2017
    Inventors: Hiep Tran, Alexander Taylor, Gisela Marquez, Christine Prokopowitz, Rolf Swoboda